Patients taking anti-obesity medications such as orlistat, phentermine/topiramate, naltrexone-bupropion, liraglutide, and semaglutide have been shown to lose 5%-12% more weight than those following a lifestyle plan alone.
Anti-obesity medications are approved for patients with a BMI ≥ 30 or a BMI ≥ 27 with a comorbidity. Other considerations include patients who are actively engaged in self-care, conscientious of their diet but struggling to make dietary changes, unable to lose or maintain a lower body weight, and who have a desire for improved health.
Most anti-obesity medications are intended for long-term use, as discontinuation may result in re-emergence of increased appetite and weight regain. An exception to this is phentermine, which is approved for short-term use only.
Anti-obesity medications should be used in conjunction with lifestyle modifications.
Learn more about anti-obesity medications.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori, Evelyn S. Marienberg. Fast Five Quiz: Weight Loss - Medscape - Nov 08, 2022.